What's happened in five years that have caught their attention, that they object to? Well, of course, abortion opponents have always

been trying to restrict access to this safe medication because medication abortion care is such a critical part of the abortion access landscape.

Today, nearly two thirds of U.S. abortions are provided using medication abortion care.

And mifepristone is part of the most common and recommended protocol for medication abortion in the United States.

So when the FDA first approved this medication back in 2000, it did so subject to a set of special medically unnecessary restrictions that leading medical experts like the American College of OBGYNs and the AMA and many others have long objected to as providing no safety benefit while significantly burdening patient access.

During the pandemic, the ACLU brought litigation on behalf of ACOG, which represents 90% of the nation's OBGYNs, along with other leading health care groups, as well as Sister Song Women of Color Reproductive Justice Collective.

And we specifically challenged one FDA requirement that forced every mifepristone patient in the country to travel to a health center, which might be hundreds of miles away, just to be handed a pill.

Well,